Background: Aspirin (ASP)-facilitated absorption of ingested allergens is considered an exacerbating factor in the development of food allergy. Sodium cromoglycate (SCG) is used for the treatment of atopic dermatitis with food allergy, but the efficacy of SCG in ASP-exacerbated food-allergy reactions is unclear. In this study, we evaluated the effect of SCG on ASP-exacerbated food-allergic reactions, as well as allergen absorption, in egg-allergic model rats. Methods: Plasma concentrations of ovalbumin (OVA) and fluorescein isothiocyanate-labeled dextran (FD-40), a marker for nonspecific-absorption pathways, were measured after oral administration of mixtures of OVA and FD-40 in OVA-unsensitized and OVA-sensitized rats. IgE-mediated allergic reactions were evaluated by measuring changes in rectal temperature and Evans blue dye (EBD) extravasation in the intestine and liver after oral challenge with OVA. The effects of ASP and SCG on such absorption and allergic reactions were also evaluated kinetically. Results: In OVA-sensitized rats, plasma concentrations of OVA and FD-40 were significantly higher than those in unsensitized rats after oral administration. ASP increased the intestinal absorption of OVA and FD-40 via the paracellular pathway, and a lower rectal temperature and higher EBD extravasation were detected in the intestine and liver of OVA-sensitized rats. SCG ameliorated these ASP-facilitated absorptions and allergic reactions in a dose-dependent manner. In particular, high-dose SCG (195.2 μmol/kg) completely inhibited these absorptions and reactions. Conclusion: SCG can prevent ASP-exacerbated allergic reactions in patients with food allergy resulting from inhibition of increases in allergen absorption.

1.
Sicherer SH, Sampson H: Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol 2014;133:291-307.
2.
Jansen JJ, Kardinaal AF, Huijbers G, Vlieg-Boerstra BJ, Martens BP, Ockhuizen T: Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol 1994;93:446-456.
3.
Berin MC, Sampson HA: Food allergy: an enigmatic epidemic. Trends Immunol 2013;34:390-397.
4.
Morita E, Kunie K, Matsuo H: Food-dependent exercise-induced anaphylaxis. J Dermatol Sci 2007;47:109-117.
5.
Hanakawa Y, Tohyama M, Shirakata Y, Murakami S, Hashimoto K: Food-dependent exercise-induced anaphylaxis: a case related to the amount of food allergen ingested. Br J Dermatol 1998;138:898-900.
6.
Kohno K, Matsuo H, Takahashi H, Niihara H, Chinuki Y, Kaneko S, Honjoh T, Horikawa T, Mihara S, Morita E: Serum gliadin monitoring extracts patients with false negative results in challenge tests for the diagnosis of wheat-dependent exercise-induced anaphylaxis. Allergol Int 2013;62:229-238.
7.
Strait RT, Mahler A, Hogan S, Khodoun M, Shibuya A, Finkelman FD: Ingested allergens must be absorbed systemically to induce systemic anaphylaxis. J Allergy Clin Immunol 2011;127:982-989.
8.
Brockow K, Kneissl D, Valentini L, Zelger O, Grosber M, Kugler C, Werich M, Darsow U, Matsuo H, Morita E, Ring J: Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis. J Allergy Clin Immunol 2015;135:977-984.
9.
Harizi H, Gualde N: The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells. Tissue Antigens 2005;65:507-514.
10.
Botting RM: Cyclooxygenase: past, present and future. J Therm Biol 2006;31:208-219.
11.
Cant AJ, Gibson P, Dancy M: Food hypersensitivity made life threatening by ingestion of aspirin. Br Med J (Clin Res Ed) 1984;288:755-756.
12.
Matsukura S, Aihara M, Sugawara M, Kunimi Y, Matsuki M, Inoue Y, Kambara T, Ikezawa Z: Two cases of wheat-dependent anaphylaxis induced by aspirin administration but not by exercise. Clin Exp Dermatol 2010;35:233-237.
13.
Matsuo H, Morimoto K, Akaki T, Kaneko S, Kusatake K, Kuroda T, Niihara H, Hide M, Morita E: Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 2005;35:461-466.
14.
Yokooji T, Hamura K, Matsuo H: Intestinal absorption of lysozyme, an egg-white allergen, in rats: kinetics and effect of NSAIDs. Biochem Biophys Res Commun 2013;438:61-65.
15.
Yokooji T, Nouma H, Matsuo H: Characterization of ovalbumin absorption pathways in the rat intestine, including the effects of aspirin. Biol Pharm Bull 2014;37:1359-1365.
16.
Matsuo H, Kaneko S, Tsujino Y, Honda S, Kohno K, Takahashi H, Mihara S, Hide M, Aburatani K, Honjoh T, Morita E: Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on serum allergen levels after wheat ingestion. J Dermatol Sci 2009;53:241-243.
17.
Aihara M, Miyazawa M, Osuna H, Tsubaki K, Ikebe T, Aihara Y, Ikezawa Z: Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol 2002;146:466-472.
18.
Matsuo H, Yokooji T, Morita H, Ooi M, Urata K, Ishii K, Takahagi S, Yanase Y, Hiragun T, Mihara S, Hide M: Aspirin augments IgE-mediated histamine release from human peripheral basophils via Syk kinase activation. Allergol Int 2013;62:503-511.
19.
Suzuki Y, Ra C: Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy. J Pharmacol Sci 2009;110:237-244.
20.
Edwards AM: Oral sodium cromoglycate: its use in the management of food allergy. Clin Exp Allergy 1995;25(suppl 1):31-33.
21.
Juji F, Suko M: Effectiveness of disodium cromoglycate in food-dependent, exercise-induced anaphylaxis: a case report. Ann Allergy 1994;72:452-454.
22.
Ortolani C, Pastorello E, Zanussi C: Prophylaxis of adverse reactions to foods: a double-blind study of oral sodium cromoglycate for the prophylaxis of adverse reactions to foods and additives. Ann Allergy 1983;50:105-109.
23.
Basomba A, Campos A, Villalmanzo IG, Pelaez A: The effect of sodium cromoglycate (SCG) in patients with food allergies. Acta Allergol 1977, pp 95-101.
24.
Sugimura T, Tananari Y, Ozaki Y, Maeno Y, Ito S, Yoshimoto Y, Kawano K, Tanaka S: Effect of oral sodium cromoglycate in 2 children with food-dependent exercise-induced anaphylaxis (FDEIA). Clin Pediatr (Phila) 2009;48:945-950.
25.
Shichijo M, Inagaki N, Nakai N, Kimata M, Nakahata T, Serizawa I, Iikura Y, Saito H, Nagai H: The effects of anti-asthma drugs on mediator release from cultured human mast cells. Clin Exp Allergy 1998;28:1228-1236.
26.
Bissonnette EY, Enciso JA, Befus AD: Inhibition of tumour necrosis factor-alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 1995;102:78-84.
27.
Dannaeus A, Inganäs M, Johansson SG, Foucard T: Intestinal uptake of ovalbumin in malabsorption and food allergy in relation to serum IgG antibody and orally administered sodium cromoglycate. Clin Allergy 1979;9:263-270.
28.
Fälth-Magnusson K, Kjellman NI, Odelram H, Sundqvist T, Magnusson KE: Gastrointestinal permeability in children with cow's milk allergy: effect of milk challenge and sodium cromoglycate as assessed with polyethyleneglycols (PEG 400 and PEG 1000). Clin Allergy 1986;16:543-551.
29.
Andre C, Andre F, Colin L, Cavagna S: Measurement of intestinal permeability to mannitol and lactulose as a means of diagnosing food allergy and evaluating therapeutic effectiveness of disodium cromoglycate. Ann Allergy 1987;59:127-130.
30.
Takahashi A, Nakajima K, Ikeda M, Sano S, Kohno K, Morita E: Pre-treatment with misoprostol prevents food-dependent exercise-induced anaphylaxis (FDEIA). Int J Dermatol 2011;50:237-238.
31.
Dahl R, Zetterström O: The effect of orally administered sodium cromoglycate on allergic reactions caused by food allergens. Clin Allergy 1978;8:419-422.
32.
Burks AW, Sampson HA: Double-blind placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity. J Allergy Clin Immunol 1988;81:417-423.
33.
Shin HY, Kim JS, An NH, Park RK, Kim HM: Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Life Sci 2004;74:2877-2887.
34.
de Oliveira AP, Lino-Dos-Santos-Franco A, Hamasato EK, Quinteiro-Filho W, Hebeda CB, Damazo AS, Farsky SH, Tavares-de-Lima W, Palermo-Neto J: Amphetamine modulates cellular recruitment and airway reactivity in a rat model of allergic lung inflammation. Toxicol Lett 2011;200:117-123.
35.
Yokooji T, Okamura Y, Chinuki Y, Morita E, Harada S, Hiragun M, Hide M, Matsuo H: Prevalences of specific IgE to wheat gliadin components in patients with wheat-dependent exercise-induced anaphylaxis. Allergol Int 2015;64:206-208.
36.
Sun N, Wang J, Zhou C, Wang C, Wang S, Che H: Cell-based immunological assay: complementary applications in evaluating the allergenicity of foods with FAO/WHO guidelines. Food Res Int 2014;62:735-745.
37.
Li Z, Gao Y, Wang H, Liu Z: A rat model of Shuang Huang Lian injection-induced anaphylaxis. Asian Pac J Allergy Immunol. 2010;28:185-191.
38.
Adachi R, Nakamura R, Sakai S, Fukutomi Y, Teshima R: Sensitization to acid-hydrolyzed wheat protein by transdermal administration to BALB/c mice, and comparison with gluten. Allergy 2012;67:1392-1399.
39.
Miyasaka CK, Mendonça JR, Silva ZL, de Sousa JA, Tavares de Lima W, Curi R: Modulation of hypersensitivity reaction by lipids given orally. Gen Pharmacol 1999;32:597-602.
40.
Horibe Y, Hosoya K, Kim KJ, Ogiso T, Lee VH: Polar solute transport across the pigmented rabbit conjunctiva: size dependence and the influence of 8-bromo cyclic adenosine monophosphate. Pharm Res 1997;14:1246-1251.
41.
Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD: Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002;109:658-668.
42.
Ahrens R, Osterfeld H, Wu D, Chen CY, Arumugam M, Groschwitz K, Strait R, Wang YH, Finkelman FD, Hogan SP: Intestinal mast cell levels control severity of oral antigen-induced anaphylaxis in mice. Am J Pathol 2012;180:1535-1546.
43.
Wojnar RJ, Hearn T, Starkweather S: Augmentation of allergic histamine release from human leukocytes by nonsteroidal anti- inflammatory-analgesic agents. J Allergy Clin Immunol 1980;66:37-45.
44.
Marone G, Kagey-Sobotka A, Lichtenstein LM: Control mechanisms of histamine release from human basophils in vitro: the role of phospholipase A2 and of lipoxygenase metabolites. Int Arch Allergy Appl Immunol 1981;66:144-148.
45.
Matsubara T, Aoki N, Honjoh T, Mizumachi K, Kurisaki J, Okajima T, Nadano D, Matsuda T: Absorption, migration and kinetics in peripheral blood of orally administered ovalbumin in a mouse model. Biosci Biotechnol Biochem 2008;72:2555-2565.
46.
Lee M, Feldman M: Age-related reductions in gastric mucosal prostaglandin levels increase susceptibility to aspirin-induced injury in rats. Gastroenterology 1994;107:1746-1750.
47.
Naito Y, Yoshikawa T, Yagi N, Matsuyama K, Yoshida N, Seto K, Yoneta T: Effects of polaprezinc on lipid peroxidation, neutrophil accumulation, and TNF-alpha expression in rats with aspirin-induced gastric mucosal injury. Dig Dis Sci 2001;46:845-851.
48.
Suzuki T, Yoshida N, Nakabe N, Isozaki Y, Kajikawa H, Takagi T, Handa O, Kokura S, Ichikawa H, Naito Y, Matsui H, Yoshikawa T: Prophylactic effect of rebamipide on aspirin-induced gastric lesions and disruption of tight junctional protein zonula occludens-1 distribution. J Pharmacol Sci 2008;106:469-477.
49.
Oshima T, Miwa H, Joh T: Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am J Physiol Cell Physiol 2008;295:C800-C806.
50.
Berin MC, Kiliaan AJ, Yang PC, Groot JA, Taminiau JA, Perdue MH: Rapid transepithelial antigen transport in rat jejunum: impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997;113:856-864.
51.
Sakamoto Y, Ohtsuka T, Yoshida H, Ohto K, Onobori M, Matsumoto T, Iikura Y, Morohoshi T: Time course of changes in the intestinal permeability of food-sensitized rats after oral allergen challenge. Pediatr Allergy Immunol 1998;9:20-24.
52.
Chen T, Liu X, Ma L, He W, Li W, Cao Y, Liu Z: Food allergens affect the intestinal tight junction permeability in inducing intestinal food allergy in rats. Asian Pac J Allergy Immunol 2014;32:345-353.
53.
Yu LC: Intestinal epithelial barrier dysfunction in food hypersensitivity. J Allergy (Cairo) 2012;2012:1-11.
54.
Berin MC, Kiliaan AJ, Yang PC, Groot JA, Kitamura Y, Perdue MH: The influence of mast cells on pathways of transepithelial antigen transport in rat intestine. J Immunol 1998;161:2561-2566.
55.
Yang PC, Berin MC, Perdue MH: Enhanced antigen transport across rat tracheal epithelium induced by sensitization and mast cell activation. J Immunol 1999;163:2769-2776.
56.
Perdue MH, McKay DM: Integrative immunophysiology in the intestinal mucosa. Am J Physiol 1994;267:G151-G165.
57.
Scudamore CL, Jepson MA, Hirst BH, Miller HR: The rat mucosal mast cell chymase, RMCP-II, alters epithelial cell monolayer permeability in association with altered distribution of the tight junction proteins ZO-1 and occludin. Eur J Cell Biol 1998;75:321-330.
58.
Patrick MK, Dunn IJ, Buret A, Miller HR, Huntley JF, Gibson S, Gall DG: Mast cell protease release and mucosal ultrastructure during intestinal anaphylaxis in the rat. Gastroenterology 1988;94:1-9.
59.
McKay DM, Bienenstock J: The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 1994;15:533-538.
60.
Bijlsma PB, Kiliaan AJ, Scholten G, Heyman M, Groot JA, Taminiau JA: Carbachol, but not forskolin, increases mucosal-to-serosal transport of intact protein in rat ileum in vitro. Am J Physiol 1996;271:G147-G155.
61.
Weangsripanaval T, Murota K, Murakami Y, Kominami M, Kusudo T, Moriyama T, Ogawa T, Kawada T: Sodium cromoglycate inhibits absorption of the major soybean allergen, Gly m Bd 30K, in mice and human intestinal Caco-2 cells. J Nutr 2006;136:2874-2880.
62.
Löbenberg R, Amidon GL: Modern bioavailability, bioequivalence and biopharmaceutics classification system: new scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000;50:3-12.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.